Birdwatch Note
2022-11-26 01:54:18 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
There is no source for this claim, and in fact a similar claim was debunked by Snopes last year. https://www.snopes.com/fact-check/japan-ivermectin-covid-vaccine/ The Japanese manufacturer of Ivermectin states it is not effective for Covid and they do not market it as a Covid-19 treatment. https://www.japantimes.co.jp/news/2022/10/02/national/science-health/kowa-ivermectin-covid-19/
Written by C114AE7443E7B8F37927077AEBFF939CF496CCF90C3DC24ACA95F015E2AB6DC7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1596244793470119936
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1596321415849992194
- noteId - 1596321415849992194
- participantId - C114AE7443E7B8F37927077AEBFF939CF496CCF90C3DC24ACA95F015E2AB6DC7
- noteAuthorParticipantId -
- createdAtMillis - 1669427658415
- tweetId - 1596244793470119936
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- There is no source for this claim, and in fact a similar claim was debunked by Snopes last year. https://www.snopes.com/fact-check/japan-ivermectin-covid-vaccine/ The Japanese manufacturer of Ivermectin states it is not effective for Covid and they do not market it as a Covid-19 treatment. https://www.japantimes.co.jp/news/2022/10/02/national/science-health/kowa-ivermectin-covid-19/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2022-11-26 01:54:18 UTC (1669427658415) |
2022-11-26 16:10:05 UTC (1669479005019) |
CURRENTLY_RATED_HELPFUL | 2022-11-26 16:10:05 UTC (1669479005019) |
CURRENTLY_RATED_HELPFUL | 2022-11-26 16:10:05 UTC (1669479005019) |
CURRENTLY_RATED_HELPFUL | C114AE7443E7B8F37927077AEBFF939CF496CCF90C3DC24ACA95F015E2AB6DC7 |
Note Ratings
| rated at | rated by | |
| 2022-11-26 20:19:45 -0600 | 0235713CA13AEDACC4696FDB703161416B12C306EB89A68285A24DD5C6560C9E | Rating Details |
| 2022-11-26 01:10:56 -0600 | 082D7880988D60E41363C038B7319A83F8F316B2655E08364AE3752EA34C9EC7 | Rating Details |
| 2022-11-26 08:12:31 -0600 | 0B683F53A71314B5B037053E967D8B7476EE62CEC7C245474E462A3294BE2995 | Rating Details |
| 2022-11-28 16:01:54 -0600 | 227B72516F48209D4CD398BD566B39A53B64980200BCA4A4C749072F49AA8384 | Rating Details |
| 2022-11-26 08:43:07 -0600 | 2E17E617CF4BFEE7E6ABEB980B32F6671382849945764F2CE25A94AB18106352 | Rating Details |
| 2022-11-26 14:49:08 -0600 | 2F1E148E62276FF995A4480A9B87C1F2CAAFC522D4E432927F446677D1ACD5FE | Rating Details |
| 2022-11-25 20:18:10 -0600 | 33CD18E8B33E288A1DD75E9EE879DBE9325F1729873AA25DDE2F2BE2F4D7174E | Rating Details |
| 2022-11-26 17:58:36 -0600 | 3624896A063D7C96A7D5CEC19E42BF0A7BF211D63967DC388752CF2F6FFEF7D3 | Rating Details |
| 2022-11-26 22:35:21 -0600 | 402B540523477342514CCBFB8666A02B089D96DD1F4F411E97879DB801B9D532 | Rating Details |
| 2022-11-27 11:17:27 -0600 | 4154671BBEB288C2F9229F391512F71C980F8202996A3CCB4F2777DBA889E18A | Rating Details |
| 2022-11-26 08:39:48 -0600 | 442C29622612F9BE2EC1F00D7F3B80B1034084BDC7FC3F0AB0BD46C440845B55 | Rating Details |
| 2022-11-26 03:55:44 -0600 | 547B46B38A1CB3060240F9F561852ADB212E08AA27CDAE1D9BE8DDCD9A5D2518 | Rating Details |
| 2022-11-26 01:58:17 -0600 | 54A6423CC2B86D48B1116EE80B255A2C6D875A2AC3F7149DCB4863961D4A463D | Rating Details |
| 2022-11-27 21:43:23 -0600 | 6F8B57C16D37301FA1BF8812048F635AFCF3D8177BF724FADA86CDFE00691408 | Rating Details |
| 2022-11-26 06:20:58 -0600 | 70C181B24233FF8251A370E67F314FF2678F046BCC2BD211A42D44AC787BC7DC | Rating Details |
| 2022-11-26 11:16:47 -0600 | 72B86190A1990254B9E1697FBB07F9088FE2C4D902304A67B7BF5412F69CE6F9 | Rating Details |
| 2022-11-26 02:20:26 -0600 | 75DE5091E62053B99DD7EBEBFF9749047814415565DFD373C77AA987F69444BC | Rating Details |
| 2022-11-25 22:42:29 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
| 2022-11-26 11:33:06 -0600 | 7DCD74A7CD5CB4959D04BF08AD7FEA450022A8AA69263A171FD1DA34832F542A | Rating Details |
| 2022-11-27 11:08:02 -0600 | 9745E3530ED4E83C3AF8D4A2D7475403FC02F16FC79B4C40717029F791E683A7 | Rating Details |
| 2022-12-18 16:57:44 -0600 | 99956CAFCE783FAB0A1F6DC1461DBF09DE8D6178BECDCFC4BE89332469B19A0D | Rating Details |
| 2022-11-26 20:43:38 -0600 | 9BD72F168FD587977B94D2EF78AEFBEFD18E02ACB3626439D900641E2770C40E | Rating Details |
| 2022-11-26 11:20:10 -0600 | 9D63BA103D90D8A76C6AE87E7D28DC98DD609186A0BDB59AB7FE8975ADA24401 | Rating Details |
| 2022-11-26 09:38:06 -0600 | 9FDAD38C91366B2DA147E11D8758B531F1A9F1E320A90036C6D6A23AD4EFD515 | Rating Details |
| 2022-11-26 07:41:10 -0600 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
| 2022-11-26 09:22:15 -0600 | A6706C9E1EE61DDA58847C2ACBE535C663BA583C6BB50C9326A09022B090B683 | Rating Details |
| 2022-11-26 07:33:41 -0600 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
| 2022-11-26 07:03:17 -0600 | AA666C86270B66AFD57DA5384BEA3E6506A9771CE51322EF624604E00E0CA72B | Rating Details |
| 2022-11-26 12:08:36 -0600 | B58FC591E8C96DE13676245FFD327D1A6F48B39F0D4D0298B1C0B07D02B268FD | Rating Details |
| 2022-11-26 07:51:57 -0600 | B6632C0206D16008A6D58872AD14BF223CD562B2DDB0AA99BE12290FC4D91B97 | Rating Details |
| 2022-11-26 08:17:16 -0600 | B81E5BB254A609770A08D4E04F69B8CB7C54F95A427285D9EE541F8FF802D29D | Rating Details |
| 2022-11-26 14:05:09 -0600 | B970847BAA982EDF58E0D0E4054BDB2CB75A976A7C4A2EED0E21DB6B18C036D3 | Rating Details |
| 2022-11-26 16:49:47 -0600 | BC80A7C6F820A223FB8677DE584F444EF275398D90BE9054F3B503BAA6B2403B | Rating Details |
| 2022-11-25 23:41:58 -0600 | CD4462E0ADDDC34E6C49FD22579E48A59F780AAEB9CE2CA216C1301497E6C8A5 | Rating Details |
| 2022-11-26 08:54:24 -0600 | DBC322B9382DDED44E9CCC0019C17752740C91A86743EC20A05A6804A000E383 | Rating Details |
| 2022-11-27 14:06:44 -0600 | DD2188A7A961E7FD93774018DF7800FE5F470A7A3C846DBD1F4D91E432FF71F5 | Rating Details |
| 2022-11-26 20:33:23 -0600 | DF2603ED06430B3E61C6BC244E5C4C7388BDAEA4D020F74C53F3FFD4AA3EFCE3 | Rating Details |
| 2022-11-26 05:26:17 -0600 | E2230465F8B028D6BF14B5E459866082CC556F31D0BD384CCDC0EF55F9A3C9D4 | Rating Details |
| 2022-11-26 00:06:03 -0600 | E343F092F0B44A6E8DEC7F3A16DFE90A5DA9F420CB1B9EDE2292D0B45E00C827 | Rating Details |
| 2022-11-25 21:55:40 -0600 | ED631A047550482645D6AF42E75C31CF2FE81AC9C6220396E1657D510F2C2F7C | Rating Details |
| 2022-11-26 07:55:24 -0600 | FC36FD2F9474B81DFF8A1CFDBA500C43C5AE6A6B9FD3FF78C947B7ADF9B9E448 | Rating Details |
| 2022-11-26 07:50:16 -0600 | FCDF3DAEF4FE8CF72ACC794461BB8C723D11E290E995AC11078ADF9011D4B647 | Rating Details |
| 2022-11-26 09:40:13 -0600 | Rating Details | |
| 2022-11-26 18:11:05 -0600 | Rating Details | |
| 2022-11-26 17:56:19 -0600 | Rating Details | |
| 2022-11-26 13:45:17 -0600 | Rating Details | |
| 2022-11-26 05:26:17 -0600 | Rating Details | |
| 2022-11-26 08:12:31 -0600 | Rating Details | |
| 2022-11-26 09:40:13 -0600 | Rating Details | |
| 2022-11-26 09:22:15 -0600 | Rating Details | |
| 2022-11-26 22:35:21 -0600 | Rating Details | |
| 2022-11-26 14:05:09 -0600 | Rating Details | |
| 2022-11-26 11:20:10 -0600 | Rating Details | |
| 2022-11-26 08:39:48 -0600 | Rating Details | |
| 2022-11-26 08:17:16 -0600 | Rating Details | |
| 2022-11-25 21:55:40 -0600 | Rating Details | |
| 2022-11-27 11:17:27 -0600 | Rating Details | |
| 2022-11-26 20:43:38 -0600 | Rating Details | |
| 2022-11-26 07:51:57 -0600 | Rating Details | |
| 2022-11-26 12:08:36 -0600 | Rating Details | |
| 2022-11-26 06:20:58 -0600 | Rating Details | |
| 2022-11-26 07:03:17 -0600 | Rating Details | |
| 2022-11-26 08:54:24 -0600 | Rating Details | |
| 2022-11-26 07:33:41 -0600 | Rating Details | |
| 2022-11-26 17:58:36 -0600 | Rating Details | |
| 2022-11-26 00:06:03 -0600 | Rating Details | |
| 2022-11-26 18:11:05 -0600 | Rating Details | |
| 2022-11-26 20:19:45 -0600 | Rating Details | |
| 2022-11-27 14:06:44 -0600 | Rating Details | |
| 2022-11-26 09:38:06 -0600 | Rating Details | |
| 2022-11-26 14:49:08 -0600 | Rating Details | |
| 2022-11-26 20:33:23 -0600 | Rating Details | |
| 2022-11-26 01:58:17 -0600 | Rating Details | |
| 2022-11-26 16:49:47 -0600 | Rating Details | |
| 2022-12-18 16:57:44 -0600 | Rating Details | |
| 2022-11-25 22:42:29 -0600 | Rating Details | |
| 2022-11-26 17:56:19 -0600 | Rating Details | |
| 2022-11-26 07:41:10 -0600 | Rating Details | |
| 2022-11-26 01:10:56 -0600 | Rating Details | |
| 2022-11-26 11:33:06 -0600 | Rating Details | |
| 2022-11-26 03:55:44 -0600 | Rating Details | |
| 2022-11-26 11:16:47 -0600 | Rating Details | |
| 2022-11-26 07:50:16 -0600 | Rating Details | |
| 2022-11-27 21:43:23 -0600 | Rating Details | |
| 2022-11-28 16:01:54 -0600 | Rating Details | |
| 2022-11-25 23:41:58 -0600 | Rating Details | |
| 2022-11-26 07:55:24 -0600 | Rating Details | |
| 2022-11-26 08:43:07 -0600 | Rating Details | |
| 2022-11-26 02:20:26 -0600 | Rating Details | |
| 2022-11-25 20:18:10 -0600 | Rating Details | |
| 2022-11-26 13:45:17 -0600 | Rating Details |